48 Hour Discovery Inc.(48HD) is a biotechnology company with a powerful new technology platform for peptide-based drug discovery We named our company 48Hour Discovery because our technology can discover drug leads in days rather than months.
We accelerate drug discovery to find new and better drugs in massively high-throughput screens using powerful technology based on DNA-encoded molecular libraries and proprietary algorithms. Using our patented technology, which combines phage display and next generation sequencing, billions of unique peptides can be screened within weeks.
We currently provide peptide-based drug discovery services for global pharmaceutical companies and also utilize the platform for three internal discovery programs. The global peptide therapeutics market was valued at $21.5 billion (USD) in 2016 and is expected to grow at a CAGR of 9.4% over the forecast period. (Grand View Research 2017).
Our unique platform enables the rapid identification of both standard and macrocyclic peptides, which exhibit excellent potency, selectivity, and GI stability for oral delivery. In addition, our technology is well suited for cell based targets, an area of drug discovery that has traditionally been challenging for peptides and antibodies.